-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data
Regeneron Pharmaceuticals (REGN) stock is on the rise Thursday after the company released its latest clinical trial data on Dupixent.
ZURA Stock Alert: Zura Bio SPAC Merger Rally Ends
Zura Bio (ZURA) stock is on the move Thursday following the clinical-stage biotechnology company's public debut earlier this week.
Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?
Cidara Therapeutics (CDTX) stock is falling on Thursday despite the immunotherapy company getting positive news from the FDA.
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?
ZyVersa Therapeutics (ZVSA) stock is taking off on Thursday morning without any recent news from the biopharmaceutical company.
ZURA Stock Alert: Low-Float Zura Bio Rockets 300%
After a shaky trading debut, ZURA stock has been skyrocketing all day. However, its low float may raise some concerns.
Why Is 89bio (ETNB) Stock Up 34% Today?
89bio (ETNB) stock is taking off on Wednesday after the company posted results from a Phase 2b clinical trial of pegozafermin.
Why Is Altimmune (ALT) Stock Down 67% Today?
Altimmune (ALT) stock is losing value on Tuesday after the company released results from a Phase 2 clinical trial for obesity.
Why Is Pear Therapeutics (PEAR) Stock Up 21% Today?
Pear Therapeutics (PEAR) stock is climbing higher on Tuesday despite the company's plans to explore strategic alternatives.
Why Is Karuna Therapeutics (KRTX) Stock Moving Today?
Karuna Therapeutics (KRTX) stock is on the move Monday after releasing positive results from a Phase 3 clinical trial for KarXT.
Dear JMAC Stock Fans, Mark Your Calendars for March 20
Maxpro Capital Acquisition is in the spotlight as shareholders approach a merger vote on Monday. JMAC stock was briefly halted on Friday.
Why Is Sarepta Therapeutics (SRPT) Stock Down 20% Today?
Sarepta Therapeutics (SRPT) stock is sliding lower on Friday after the company announced an advisory committee meeting with the FDA.
Why Is Histogen (HSTO) Stock Up 37% Today?
Histogen (HSTO) stock is rising higher on Friday after getting a patent for CTS-2090 that protects its products through 2040.
Why Is Enzo Biochem (ENZ) Stock Up 72% Today?
Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH).